Cancer Which Has Either Progressed or Relapsed After Standard Therapy, or for Which no Curative or Standard Therapy is Appropriate (1)

Completed (1)

phase 1 (1)

Eagle Pharmaceuticals, Inc. (1)

test product (bendamustine) (1)

drug (1)

Industry (1)

Interventional (1)

cancer which has either progressed or relapsed after standard therapy, or for which no curative or standard therapy is appropriate

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Completed

Cancer Which Has Either Progressed or Relapsed After Standard Therapy, or for Which no Curative or Standard Therapy is Appropriate

Jun 2, 2021